Lantheus Holdings (LNTH) Prepaid Assets (2014 - 2026)
Lantheus Holdings' (LNTH) quarterly Prepaid Assets came in at $25.2 million in Q1 2026, down 62.57% year-on-year from $67.4 million in Q1 2025, and up 17.82% on a QoQ basis from $21.4 million in Q4 2025.
Lantheus Holdings (LNTH) Prepaid Assets (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 13 years of Prepaid Assets data on file, last reported at $25.2 million in Q1 2026.
- On a quarterly basis, Prepaid Assets fell 62.57% year-over-year to $25.2 million in Q1 2026; TTM through Mar 2026 was $25.2 million, a 62.57% decrease from a year earlier, with the FY2025 full-year figure at $21.4 million, up 38.91% from the prior year.
- Prepaid Assets for Q1 2026 stood at $25.2 million, up from $21.4 million in the prior quarter.
- Over the last five years, Prepaid Assets for LNTH reached as high as $67.4 million in Q1 2025 and fell as low as $10.9 million in Q1 2023.
- Historically, Prepaid Assets has averaged $21.2 million across 5 years, with a median of $16.7 million in 2023.
- Across the five-year window, Prepaid Assets jumped 315.49% in 2025 and tumbled 62.57% in 2026, its largest moves.
- Year by year, Prepaid Assets stood at $13.1 million in 2022, then gained by 27.43% to $16.7 million in 2023, then fell by 7.65% to $15.4 million in 2024, then soared by 38.91% to $21.4 million in 2025, then gained by 17.82% to $25.2 million in 2026.
- Per Business Quant data, the three most recent Prepaid Assets figures were $25.2 million in Q1 2026, $21.4 million in Q4 2025, and $21.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Lantheus Holdings | 6.72 Bn | 6.22 Bn | 230.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.21 Mn |
| Dec 31, 2025 | 21.40 Mn |
| Sep 30, 2025 | 21.17 Mn |
| Jun 30, 2025 | 34.09 Mn |
| Mar 31, 2025 | 67.37 Mn |
| Dec 31, 2024 | 15.41 Mn |
| Sep 30, 2024 | 22.00 Mn |
| Jun 30, 2024 | 24.17 Mn |
| Mar 31, 2024 | 16.22 Mn |
| Dec 31, 2023 | 16.68 Mn |
| Sep 30, 2023 | 11.49 Mn |
| Jun 30, 2023 | 22.91 Mn |
| Mar 31, 2023 | 10.95 Mn |
| Dec 31, 2022 | 13.09 Mn |
| Sep 30, 2022 | 12.57 Mn |
| Jun 30, 2022 | 11.99 Mn |
| Mar 31, 2022 | 12.86 Mn |
| Dec 31, 2021 | 12.82 Mn |
| Sep 30, 2021 | 12.04 Mn |
| Jun 30, 2021 | 8.10 Mn |